Mast cells and inflammation

Archivum Immunologiae et Therapiae Experimentalis

Volumn 50, Issue 3, 2002, Pages 179-185

  Stassen, Michael ^a   Hültner, Lothar ^b   Müller, Christian ^a   Schmitt, Edgar ^a,c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

IgE inclependent activation; Inflammation; Innate immune response; Mast cells

Indexed keywords

ANIMAL; ANTIGEN ANTIBODY COMPLEX; AUTOIMMUNE DISEASE; DELAYED HYPERSENSITIVITY; HUMAN; HYPERSENSITIVITY; INFLAMMATION; INNATE IMMUNITY; MAST CELL; PHYSIOLOGY; REVIEW;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; AUTOIMMUNE DISEASES; HUMANS; HYPERSENSITIVITY; HYPERSENSITIVITY, DELAYED; IMMUNITY, NATURAL; INFLAMMATION; MAST CELLS;

EID: 0042368607     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. ASKENASE P. W., BURSZTAJN S., GERSHON M. D. and GERSHON R. K. (1980): T cell-dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity. J. Exp Med., 152, 1358-1374.
2. ASKENASE P. W., VAN LOVEREN H., KRAEUTER-KOPS S., RON Y., MEADE R., THEOHARIDES T. C., NORDLUND J. J., SCOVERN H., GERHSON M. D. and PTAK W. (1983): Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice. J. Immunol., 131, 2687-2694.
3. AUSTEN K. F. and BOYCE J. A. (2001): Mast cell lineage development and phenotypic regulation. Leuk. Res., 25, 511-518.
4. BARAM D., VADAY G. G., SALAMON P., DRUCKER I., HERSHKOVIZ R. and MEKORI Y. A. (2001): Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha. J. Immunol., 167, 4008-4016.
5. BAUMANN U., CHOUCHAKOVA N., GEWECKE B., KOHL J., CARROLL M. C., SCHMIDT R. E. and GESSNER J. E. (2001): Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung. J. Immunol., 167, 1022-1027.
6. BAUMANN U., KOHL J., TSCHERNIG T., SCHWERTER-STRUMPF K., VERBEEK J. S., SCHMIDT R. E. and GESSNER J. E. (2000): A codominant role of Fc gamma RI/III and C5aR in the reverse Arthus reaction. J. Immunol., 164, 1065-1070.
7. BEBO B. F. JR., YONG T., ORR E. L. and LINTHICUM D. S. (1996): Hypothesis: a possible role for mast cells and their inflammatory mediators in the pathogenesis of autoimmune encephalomyelitis. J. Neurosci. Res., 45, 340-348.
8. BIEDERMANN T., KNEILLING M., MAILHAMMER R., MAIER K., SANDER C. A., KOLLIAS G., KUNKEL S. L., HULTNER L. and ROCKEN M. (2000): Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med., 192, 1441-1452.
9. BOES M., PRODEUS A. P., SCHMIDT T., CARROLL M. C. and CHEN J. (1998): A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J. Exp. Med., 188, 2381-2386.
10. BUSSE W. W. and LEMANSKE R. F. JR. (2001): Asthma. N. Engl. J. Med., 344, 350-362.
11. ECHTENACHER B., FALK W., MANNEL D. N. and KRAMMER P. H. (1990): Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol., 145, 3762-3766.
12. ECHTENACHER B., MANNEL D. N. and HULTNER L. (1996): Critical protective role of mast cells in a model of acute septic peritonitis. Nature, 381, 75-77.
13. GALLI S. J., MAURER M. and LANTZ C. S. (1999): Mast cells as sentinels of innate immunity. Curr. Opin. Immunol., 11, 53-59.
14. GOMMERMAN J. L., OH D. Y., ZHOU X., TEDDER T. F., MAURER M., GALLI S. J. and CARROLL M. C. (2000): A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation. J. Immunol., 165, 6915-6921.
15. GORDON J. R. and GALLI S. J. (1990): Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature, 346, 274-276.
16. GORDON J. R. and GALLI S. J. (1991): Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J. Exp. Med., 174, 103-107.
17. HAZENBOS W. L., GESSNER J. E., HOFHUIS F. M., KUIPERS H., MEYER D., HEIJNEN I. A., SCHMIDT R. E., SANDOR M., CAPEL P. J., DAERON M., VAN DE WINKEL J. G. and VERBEEK J. S. (1996): Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice. Immunity, 5, 181-188.
18. HOPKEN U. E., LU B., GERARD N. P. and GERARD C. (1997): Impaired inflammatory responses in the reverse Arthus reaction through genetic deletion of the C5a receptor. J. Exp. Med., 186, 749-756.
19. HULTNER L., KOLSCH S., STASSEN M., KASPERS U., KREMER J. P., MAILHAMMER R., MOELLER J., BROSZEIT H. and SCHMITT E. (2000): In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9. J. Immunol., 164, 5556-5563.
20. INAMURA N., MEKORI Y. A., BHATTACHARYYA S. P., BIANCHINE P. J. and METCALFE D. D. (1998): Induction and enhancement of Fc(epsilon)RI-dependent mast cell degranulation following coculture with activated T cells: dependency on ICAM-1-and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation. J. Immunol., 160, 4026-4033.
21. JANOFF A., KLASSEN A. and TROLL W. (1970): Local vascular changes induced by the cocarcinogen, phorbol myristate acetate. Cancer Res., 30, 2568-2571.
22. KITAMURA Y., HIROTA S., MORII E. and NISHIDA T. (2000): Gain-of-function mutations of c-kit in human diseases. In MARONE G., LICHTENSTEIN L. M. and GALLI S. J.: Mast Cells and Basophils. Academic Press, New York, 21-29.
23. KRANEVELD A. D., MUIS T., KOSTER A. S. and NIJKAMP F. P. (1998): Role of mucosal mast cells in early vascular permeability changes of intestinal DTH reaction in the rat. Am. J. Physiol., 274, G832-G839.
24. KRISHNASWAMY G., LAKSHMAN T., MILLER A. R., SRIKANTH S., HALL K., HUANG S. K., SUTTLES J., SMITH J. K. and STOUT R. (1997): Multifunctional cytokine expression by human mast cells: regulation by T cell membrane contact and glucocorticoids. J. Interferon Cytokine Res., 17, 167-176.
25. MALAVIYA R. and ABRAHAM S. N. (2000): Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J. Leukoc. Biol., 67, 841-846.
26. MALAVIYA R. and ABRAHAM S. N. (2001): Mast cell modulation of immune responses to bacteria Immunol. Rev., 179, 16-24.
27. MALAVIYA R., IKEDA T., Ross E. and ABRAHAM S. N. (1996): Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature, 381, 77-80.
28. MAURER M., ECHTENACHER B., HULTNER L., KOLLIAS G., MANNEL D. N., LANGLEY K. E. and GALLI S. J. (1998): The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J. Exp. Med., 188, 2343-2348.
29. METCALFE D. D., BARAM D. and MEKORI Y. A. (1997): Mast cells. Physiol. Rev., 77, 1033-1079.
30. OCHSENBEIN A. F. and ZINKERNAGEL R. M. (2000): Natural antibodies and complement link innate and acquired immunity. Immunol. Today, 21, 624-630.
31. PRODEUS A. P., ZHOU X., MAURER M., GALLI S. J. and CARROLL M. C. (1997): Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature, 390, 172-175.
32. QURESHI R. and JAKSCHIK B. A. (1988): The role of mast cells in thioglycollate-induced inflammation. J. Immunol., 141, 2090-2096.
33. RAMOS B. F., QURESHI R., OLSEN K. M. and JAKSCHIK B. A. (1990): The importance of mast cells for the neutrophil influx in immune complex-induced peritonitis in mice. J. Immunol., 145, 1868-1873,
34. RAMOS B. F., ZHANG Y. and JAKSCHIK B. A. (1994): Neutrophil elicitation in the reverse passive Arthus reaction. Complement-dependent and -independent mast cell involvement. J. Immunol., 152, 1380-1384.
35. RENAULD J. C. (2001): New insights into the role of cytokincs in asthma. J. Clin. Pathol., 54, 577-589.
36. ROSENKRANZ A. R., COXON A., MAURER M., GURISH M. F., AUSTEN K. F., FRIEND D. S., GALLI S. J. and MAYADAS T. N. (1998): Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice. J. Immunol., 161, 6463-6467.
37. SECOR V. H., SECOR W. E., GUTEKUNST C. A. and BROWN M. A. (2000): Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med., 191, 813-822.
38. SHER A. (1976): Complement-dependent adherence of mast cells to schistosomula. Nature, 263, 334-336.
39. SHER A., HEIN A., MOSER G. and CAULFIELD J. P. (1979): Complement receptors promote the phagocytosis of bacteria by rat peritoneal mast cells. Lab. Invest., 41, 490-499.
40. SHER A. and MCINTYRE S. L. (1977): Receptors for C3 on rat peritoneal mast cells. J. Immunol., 119, 722-725.
41. STASSEN M., ARNOLD M., HULTNER L., MÜLLER C., NEUDORFL C., REINEKE T. and SCHMITT E. (2000): Murine bone marrow-derived mast cells as potent producers of 1L-9: costimulatory function of IL-IO and kit ligand in the presence of IL-1. J. Immunol., 164, 5549-5555.
42. STASSEN M., MÜLLER C., ARNOLD M., HULTNER L., KLEIN-HESSLING S., NEUDORFL C., REINEKE T., SERFLING E. and SCHMITT E. (2001): IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9. J. Immunol., 166, 4391-4398.
43. SYLVESTRE D., CLYNES R., MA M., WARREN H., CARROLL M. C. and RAVETCH J. V. (1996): Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J. Exp. Med., 184, 2585-2392.
44. SYLVESTRE D. L. and RAVETCH J. V. (1996): A dominant role for mast cell Fc receptors in the Arthus reaction. Immunity, 5, 387-390.
45. TSAI M., WEDEMEYER J., GANIATSAS S., TAM S. Y., ZON L. I. and GALLI S. J. (2000): In vivo immunological function of mast cells derived from embryonic stem cells: an approach for the rapid analysis of even embryonic lethal mutations in adult mice in vivo. Proc. Natl. Acad. Sci. USA, 97, 9186-9190.
46. WEDEMEYER J. and GALLI S. J. (2000): Mast cells and basophils in acquired immunity. Br. Med. Bull., 56, 936-955.
47. WERSHIL B. K., MURAKAMI T. and GALLI S. J. (1988): Mast cell-dependent amplification of an immunologically nonspecific inflammatory response. Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate. J. Immunol., 140, 2356-2360.
48. WERSHIL B. K., WANG Z. S., GORDON J. R. and GALLI S. J. (1991): Recruitment of neutroph Is during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J. Clin. Invest., 87, 446-453.
49. WILLIAMS C. M. and GALLI S. I. (2000): Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J. Exp. Med., 192, 455-462.
50. WILLS-KARP M. (1999): Immunologic basis of antigen-induced airway hypenesponsiveness. Annu. Rev. Immunol., 17, 255-281.
51. ZHANG Y., RAMOS B. F. and JAKSCHIK B. A. (1991): Augmentation of reverse Arthus reaction by mast cells in mice. J. Clin. Invest., 88, 841-846.
52. ZHANG Y., RAMOS B. F. and JAKSCHIK B. A. (1992): Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science, 258, 1957-1959.